Bavarian Nordic Secures $157M Contract to Replenish US Supplies of Smallpox/Mpox Vaccine Jynneos

Bavarian Nordic Secures $157M Contract to Replenish US Supplies of Smallpox/Mpox Vaccine Jynneos Bavarian Nordic, a Danish biotechnology company, has recently secured a substantial contract worth $156.8 million from the United States government to replenish the nation’s stockpile of the smallpox and mpox vaccine, Jynneos. This deal marks a significant milestone for Bavarian Nordic as […]